Sign in

CIK 0001346830

  • Non-accelerated filer
  • Smaller reporting company

Tvardi Therapeutics, Inc.

Sign in to watch
Ticker
TVRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 713-489-8654
Business address
3 SUGAR CREEK CTR. BLVD., STE 525, SUGAR LAND, TX, 77478
Former names
Cara Therapeutics, Inc., Cara Therapeutics Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-08-02 Boudreau Helen M Director Grant or award · Stock Option (Right to Buy) +155,747 155,747
2023-06-23 Terrillion Scott Sec'y; Chief Compliance & G.C. Sale 10b5-1 −2,483 $3.51 $9K 88,563
2023-06-23 Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Sale 10b5-1 −2,993 $3.51 $11K 153,747
2023-06-23 Goncalves Joana Chief Medical Officer Sale 10b5-1 −2,723 $3.51 $10K 53,681
2023-06-01 von Moltke Lisa Director Grant or award +32,362 32,362
2023-06-01 von Moltke Lisa Director Grant or award · Stock Option (Right to Buy) +44,961 44,961
2023-06-01 Shiff Susan Ph.D. Director Grant or award +32,362 51,438
2023-06-01 Shiff Susan Ph.D. Director Grant or award · Stock Option (Right to Buy) +44,961 44,961
2023-06-01 Ives Jeffrey L. Director Grant or award +32,362 47,838
2023-06-01 Ives Jeffrey L. Director Grant or award · Stock Option (Right to Buy) +44,961 44,961
2023-06-01 BAINS HARRISON M JR Director Grant or award +32,362 57,438
2023-06-01 BAINS HARRISON M JR Director Grant or award · Stock Option (Right to Buy) +44,961 44,961
2023-06-01 VOGELBAUM MARTIN Director Grant or award +64,724 109,712
2023-06-01 VOGELBAUM MARTIN Director Grant or award · Stock Option (Right to Buy) +89,923 89,923
2023-05-05 Posner Christopher President and CEO Sale 10b5-1 −3,869 $4.40 $17K 172,514
2023-04-04 Terrillion Scott Sec'y; Chief Compliance & G.C. Sale −2,481 $4.91 $12K 91,046
2023-04-04 Goncalves Joana Chief Medical Officer Sale −2,481 $4.91 $12K 56,404
2023-04-04 Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Sale −2,733 $4.91 $13K 156,740
2023-03-03 Posner Christopher President and CEO Sale −5,987 $9.71 $58K 176,383
2023-03-03 Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Sale −6,802 $9.71 $66K 159,473

Page 5 of 7 · 123 trades